How to recognize a counterfeit of Primobolan Depot (methenolone enanthate)
Primobolan Depot has a reputation as an "elite" and expensive steroid, and the original product disappeared from legal circulation in most countries long ago. This creates ideal conditions for counterfeiting. The editorial team explains why visual inspection guarantees almost nothing, what studies of seized products say, and what risks lie behind "cheap primo".
Why methenolone is counterfeited so often
The original Primobolan Depot was made by Schering (later part of Bayer). Over time the product disappeared from the markets of many countries, and the availability of the original dropped sharply. On the illegal market, however, demand for it remained high thanks to its reputation as a "clean" product with minimal estrogenic effects.
The second reason is the cost of raw material. Methenolone enanthate is more complex to synthesize and more expensive than, say, testosterone or nandrolone. For an unscrupulous manufacturer it is economically advantageous to replace the expensive substance with a cheaper one or to reduce its concentration while keeping the high price.
The third reason is the difficulty of subjective assessment. Methenolone does not cause pronounced water retention or rapid weight gain, so a person who has received a product with a reduced concentration often cannot distinguish a "weak effect of the drug" from the absence of any active substance.
Finally, the illegal market has, in principle, no quality-control mechanisms. Unlike the pharmacy chain, where Good Manufacturing Practice (GMP) requirements and an anti-counterfeiting system apply, here no one is responsible for the composition, sterility and labeling.
What is found in counterfeits
The systematic review and meta-analysis by Magnolini and colleagues (2022) summarized the results of laboratory analyses of black-market anabolic steroids published in the scientific literature. The authors concluded that a significant proportion of the analyzed samples did not match the stated composition: they contained a different substance, an incorrect dose, or no active substance at all.
| Type of discrepancy | What it means | Consequences |
|---|---|---|
| Substance substitution | A cheaper steroid instead of methenolone (for example, testosterone or nandrolone) | Unexpected estrogenic and progestagenic effects, a different risk profile |
| Understated concentration | Less active substance than on the label | The person increases the injected volume, raising the risks from other components |
| Overstated concentration | More active substance than declared | An unpredictable burden on the body |
| Absence of active substance | Oil only | Financial loss, risks from a non-sterile injection |
| Microbial or mechanical contamination | Bacteria, particles, solvent residues | Abscesses, infections, inflammatory reactions |
Substituting an aromatizing steroid for methenolone is especially insidious: a person who chose the product specifically for its lack of estrogenic effects may encounter gynecomastia or fluid retention and not understand the cause.
The World Health Organization specifically highlights the problem of substandard and falsified medical products worldwide. They are most common precisely where a regulated supply chain is absent, and the illegal market for hormonal drugs is a classic example.
External signs: what can and cannot be seen
The "guides to recognizing counterfeits" common online usually come down to inspecting the packaging. The editorial team considers it necessary to say honestly: modern counterfeits often have high-quality printing, holograms and even codes that imitate the real ones. A visual inspection can reveal a crude fake, but it cannot confirm authenticity.
- What may raise suspicion:errors in the label text, blurred printing, a mismatch between the batch number on the ampoule and the box, a missing expiry date, sediment or cloudiness of the solution, foreign particles.
- What is not proof of authenticity:a hologram, a "branded" box, a QR code, a nice-looking ampoule, the seller's assurances, forum reviews.
- Market red flags:a price noticeably below average, "unlimited" availability of a discontinued product, sale without a prescription.
The oil solution of a genuine product should be clear. Cloudiness, flakes or crystals may indicate improper manufacturing or storage, but a clear solution can just as well be a counterfeit. Color and viscosity depend on the oil base and solvents and are not a reliable criterion.
Also common are "underground laboratory" (UGL) products, which do not even claim to imitate the original but are sold under their own brands. Their composition is even harder to verify, since there is no original for comparison and the manufacturing conditions are unknown.
Laboratory testing
The only way to reliably establish the composition of a product is instrumental analysis in an accredited laboratory. Chromatographic methods combined with mass spectrometry (GC-MS, LC-MS) are most often used, allowing the substance to be identified and its concentration determined.
There are also "home" color reagent tests that respond with a color change to certain classes of compounds. They can give a rough idea of the presence of a steroid structure, but they do not determine concentration, do not reliably distinguish structurally similar steroids, and do not detect microbial contamination. They cannot be relied upon as a guarantee of quality.
None of the composition-analysis methods assess sterility. For an injectable product this is critical: a solution may contain the correct substance at the correct concentration and yet be contaminated with bacteria or endotoxins. Sterility is ensured only by manufacturing conditions, not by testing a finished vial at home.
In legal medical circulation, quality control rests with the manufacturer and the regulator. In EU countries, for example, Directive 2011/62/EU introduced safety features on the packaging of prescription medicines and a system for verifying them at the pharmacy. Outside this chain, no "check" provides comparable guarantees.
Health risks from counterfeits
The most obvious risk of a non-sterile injectable product is infectious complications at the injection site. Abscesses, phlegmons, and in severe cases systemic infections, have been described among users of illegal steroids. Treating an abscess often requires surgical incision and antibiotics.
The second risk is the unpredictability of the effect. If the vial contains a different substance or a different dose, a person cannot assess what is actually happening in their body. This also complicates diagnosis: a doctor, going by the name of the drug, may not look for the effects of the substance that was actually injected.
The third risk is impurities. Residues of organic solvents, decomposition products and unsuitable oils can cause allergic and inflammatory reactions, so-called oil granulomas, and prolonged pain at the injection site.
Finally, it is worth remembering the legal aspect: purchasing prescription hormonal drugs outside the pharmacy network breaks the law in many countries, and for athletes any such drug means a violation of anti-doping rules regardless of its actual composition.
Editorial conclusions
Primobolan Depot is one of the most attractive products for counterfeiters because of high demand, the high cost of the substance, and the disappearance of the original from legal circulation.
Studies of seized products show that a significant proportion of black-market steroids do not match the stated composition. External signs can reveal a crude fake but do not confirm authenticity, still less sterility.
The composition can be reliably established only in a laboratory, and the safety of an injectable product is ensured only by regulated manufacturing and a legal supply chain.
We also recommend reading our articles on the legal status of Primobolan Depot in Ukraine and the EU, on injection complications and abscesses, and on how doping laboratories work.
References
- Magnolini R, Falcato L, Cremonesi A, et al. Fake anabolic androgenic steroids on the black market — a systematic review and meta-analysis on qualitative and quantitative analytical results found within the literature. BMC Public Health. 2022;22:1371.
- World Health Organization. Substandard and falsified medical products: fact sheet. Geneva: WHO.
- Directive 2011/62/EU of the European Parliament and of the Council of 8 June 2011 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use, as regards the prevention of the entry into the legal supply chain of falsified medicinal products. Official Journal of the European Union. 2011;L174:74–87.
- Pope HG Jr, Wood RI, Rogol A, et al. Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocr Rev. 2014;35(3):341–375.
- Kicman AT. Pharmacology of anabolic steroids. Br J Pharmacol. 2008;154(3):502–521.
- World Anti-Doping Agency. Prohibited List. Montreal: WADA; чинна редакція.
Andriy Melnyk
A strength-sports coach and author of programs for beginner and intermediate levels. Writes about training planning.
